The document provides an overview of clinical trial regulations in India, China, and Russia. It discusses key aspects of India's regulatory history and framework, including important definitions, the roles of regulatory agencies like CDSCO and DCGI, clinical trial application requirements, and current applicable regulations like Schedule Y and GCP guidelines. It also briefly outlines the agenda for a discussion on practical experiences with QA audits in these countries.